NASD · Healthcare · Medical Devices · China
Baird Medical Investment Holdings Limited is a micro cap company (market value under $300 million) in the Medical Devices industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Baird Medical Investment Holdings Limited stock.
No reliable verdict: intrinsic value $3.07 per share, market price $0.16 (as of 2026-10-30).
Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $3.07: 19 times the price of $0.16. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
All 142 Medical Devices stocks
We do not publish a verdict on BDMD. Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $3.07: 19 times the price of $0.16. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
We do not publish one (as of the 2026-10-30 close). Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $3.07: 19 times the price of $0.16. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.